Exhibit 99.1

ExamWorks Reports Fourth Quarter 2015 Financial Results;

Revenues of $208.5 million; Adjusted EBITDA of $35.4 million;

Announces National Account Win; and

Provides 2016 Guidance

ATLANTA, GA. February 23, 2016 – ExamWorks Group, Inc. (NYSE: EXAM), a leading provider of independent medical examinations, peer reviews, bill reviews, Medicare compliance services, case management services, record retrieval services, document management services and other related services (“IME services”) today reported financial results for the fourth quarter of 2015.

Fourth Quarter 2015

Full Year 2015

 Other Highlights

Commentary

Commenting on today's earnings announcement, James K. Price, Chief Executive Officer of ExamWorks, said: “During 2015 and into 2016 we have acquired 7 great companies that strengthen our product offering and market share and allow us to offer new services to our clients, further positioning us as a key partner to our target market.  These acquisitions should add meaningfully to our 2016 results.  We are proud of our achievements in 2015 and thankful for our worldwide employees who made them happen once again.”

Richard E. Perlman, Executive Chairman of ExamWorks, said: “2015 was another year of significant accomplishments for ExamWorks in which we continued to demonstrate the stability, consistency and capacity for growth of our business even in the face of challenges.  We enter 2016 better positioned than ever and confident on the company’s ability to deliver solid results well into the future.”

Financial Review

Revenues – For the three months ended December 31, 2015, revenues were $208.5 million, an increase of 3.2% over the $202.1 million of revenues generated in the fourth quarter of 2014.

For the year ended December 31, 2015, revenues were $819.6 million, an increase of 5.7% over the $775.6 million of revenues generated in the comparable period in 2014.   

Below is a table presenting our reported revenues and growth rates for each of the regions we serve.

(a) The constant FX columns represent growth rates excluding the effects of currency.

Costs of revenues – For the three months ended December 31, 2015, costs of revenues were $137.4 million, an increase of 5.2% over the $130.6 million in costs of revenues in the fourth quarter of 2014. The increase was primarily due to increased revenues. Costs of revenues as a percentage of revenues for the fourth quarter of 2015 were 65.9% compared to 64.6% in the prior year quarter due to changes in sales mix. Included in costs of revenues in the fourth quarter of 2014 and 2015 are approximately $421,000 and $239,000 of share-based compensation expenses, respectively.

Selling, general and administrative expenses (“SGA”) – For the three months ended December 31, 2015, SGA expenses were $41.3 million, a decrease of 7.2% over the $44.5 million in SGA expenses in the fourth quarter of 2014. Adjusted SGA as a percentage of revenue was 17.2% in the fourth quarter of 2015 an improvement over the 19.1% in the comparable prior year period. This improvement was due to organic growth and improved cost structures in our U.K. and ECS businesses. Adjusted SGA excludes the impact of share based compensation and acquisition-related transaction costs and other expenses that are added back to arrive at adjusted EBITDA. Included in SGA expenses in the fourth quarter of 2015 are $4.0 million in share-based compensation expenses and $1.4 million in acquisition-related transaction costs and other expenses. Included in SGA expenses in the fourth quarter of 2014 are $4.9 million in share-based compensation expenses and $1.1 million in acquisition-related transaction costs and other expenses.

Depreciation and amortization expenses (“D&A”) – For the three months ended December 31, 2015, D&A expenses were $14.1 million, a decrease of 8.4% from the $15.4 million in D&A expenses in the fourth quarter of 2014. The decrease was due to intangible assets becoming fully amortized in 2014 and 2015, offset by amortization of finite lived intangibles resulting from recent acquisitions. For the three months ended December 31, 2015, amortization expense was $12.1 million and depreciation expense was $2.0 million.

Interest and other expenses, net – For the three months ended December 31, 2015, interest and other expenses, net, were $8.0 million, a 1.2% decrease over the $8.1 million in interest and other expenses, net in the fourth quarter of 2014.    

Adjusted EBITDA – For the three months ended December 31, 2015, adjusted EBITDA was $35.4 million, an increase of 5.7% over the $33.5 million of adjusted EBITDA generated in the fourth quarter of 2014.

For the year ended December 31, 2015, adjusted EBITDA was $140.7 million, an increase of 6.5% over the $132.1 million of adjusted EBITDA generated in the prior year.

Adjusted EBITDA is a non-GAAP measure that is described and reconciled to net income below and is not a substitute for the GAAP equivalent.

Other financial data – For the year ended December 31, 2015, we generated $50.0 million of cash flow from operations compared to $45.2 million for the prior year. We ended the quarter with $47.9 million of cash on hand and $300 million available under our senior secured revolving credit facility. Additionally, we ended the quarter with $535.2 million of total debt, consisting of $500.0 million of senior unsecured notes due April 2023 and $35.2 million outstanding under our UK discount facilities. Our total leverage to adjusted EBITDA as of the end of the fourth quarter, calculated in accordance with our senior secured credit facility, was approximately 3.4x.

Share Repurchase

The Board of Directors increased its previous share repurchase authorization, with the repurchase program authorizing the purchase of up to $75 million of outstanding shares of the Company’s common stock. Starting in December 2015 and through the date of this release, the Company repurchased approximately 1.1 million shares at an average price of $26.35 per share. The Company has approximately $36 million remaining available under its current $75 million authorization. Repurchases will be made in accordance with applicable securities laws, from time to time, in the open market, through privately negotiated transactions, or otherwise.

Business Outlook

ExamWorks is providing the following business outlook for the full year and for the first quarter of 2016 excluding any acquisitions that may be completed:

About ExamWorks Group

ExamWorks Group, Inc. is a leading provider of independent medical examinations, peer reviews, bill reviews, Medicare compliance services, case management services, record retrieval services, document management services and other related services (“IME services”). We help our clients manage costs and enhance their risk management processes by verifying the validity, nature, cause and extent of claims, identifying fraud and providing fast, efficient and quality IME services. ExamWorks is focused on providing clients a national presence while maintaining the local service and capabilities they need and expect.

Non-GAAP Financial Measures

In connection with the ongoing operation of our business, our management regularly reviews Adjusted EBITDA, a non-GAAP financial measure, to assess our performance. We define Adjusted EBITDA as earnings before interest, taxes, depreciation, amortization, acquisition-related transaction costs, share-based compensation expenses, and other expenses. We believe that Adjusted EBITDA is an important measure of our operating performance because it allows management, lenders, investors and analysts to evaluate and assess our core operating results from period to period after removing the impact of changes to our capitalization structure, acquisition-related costs, income tax status, and other items of a non-operational nature that affect comparability.

We believe that various forms of the Adjusted EBITDA metric are often used by analysts, investors and other interested parties to evaluate companies such as ours for the reasons discussed above. Additionally, Adjusted EBITDA is used to measure certain financial covenants in our credit facility. Adjusted EBITDA is also used for planning purposes and in presentations to our Board of Directors as well as in our incentive compensation programs for our employees.

Non-GAAP information should not be construed as an alternative to GAAP information, as the items excluded from the non-GAAP measures often have a material impact on our financial results. Management uses, and investors should use, non-GAAP measures in conjunction with our GAAP results.

Below is a table presenting a reconciliation to Adjusted EBITDA from net income, the most comparable GAAP measure, for each of the periods indicated.

Forward Looking Statements

Statements made in this press release that express ExamWorks' or management's intentions, plans, beliefs, expectations or predictions of future events are forward-looking statements, which ExamWorks intends to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. These statements often include words such as “may,” “will,” “should,” “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate,” or the negative of these terms or other similar expressions that convey uncertainty of future events or outcomes. Forward-looking statements may include information concerning ExamWorks' possible or assumed future results of operations, including descriptions of ExamWorks' revenues, profitability, outlook and overall business strategy. You should not place undue reliance on these statements because they are subject to numerous uncertainties and factors relating to ExamWorks' operations and business environment, all of which are difficult to predict and many of which are beyond ExamWorks' control. Although ExamWorks believes that these forward-looking statements are based on reasonable assumptions, you should be aware that many uncertainties and factors could affect ExamWorks' actual financial results or results of operations and could cause actual results to differ materially from those in the forward-looking statements, including but not limited to: our ability to implement our growth strategy and acquisition program; our ability to integrate completed acquisitions; our expansion into international markets; our increasing reliance on national account clients; our ability to secure additional financing; regulation of our industry; our information technology systems and the risk of security and data breaches; our ability to protect our intellectual property rights and other information; our ability to compete successfully with our competitors; our ability to monitor and retain qualified physicians and other medical providers; our ability to obtain, retain and grow customer relationships; our ability to provide accurate health-related risk assessment analyses of data; our ability to comply with existing and future regulation; our ability to retain key management personnel; and restrictions in our credit facility, senior notes indenture and future indebtedness. In addition, the risks discussed in our periodic reports, registration statements and other filings with the Securities and Exchange Commission could cause actual results to differ materially from the results anticipated by forward-looking statements.

You should keep in mind that any forward-looking statement made by ExamWorks herein, or elsewhere, speaks only as of the date on which made. ExamWorks expressly disclaims any intent, obligation or undertaking to update or revise any forward-looking statements made herein to reflect any change in ExamWorks' expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

ExamWorks will host a conference call to discuss the results and other matters at 5:00 p.m. Eastern Time. Please log in at least 10 minutes prior to the conference call in order to download the applicable audio software. Interested parties may participate live via telephone by dialing (888) 455-1227 in the U.S. or (773) 799-3336 internationally with access code 1941106. A live webcast of the call is also accessible through the Investor Relations section of the company’s web site at http://investorrelations.examworks.com/.

Following the conclusion of the call, a replay of the webcast will be available at the Company’s web site within two hours. Alternatively, a telephonic replay of the call will be available at 7:00 p.m. Eastern Time, and can be accessed until March 4, 2016 at midnight Eastern Time, by calling (888) 293-8936 in the U.S. or (402) 998-0528 internationally, with access code 562014.

CONTACT:

ExamWorks Group, Inc.

J. Miguel Fernandez de Castro

404-952-2400

Senior Executive Vice President and Chief Financial Officer

investorrelations@examworks.com

SOURCE: ExamWorks Group, Inc.

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Consolidated Statements of Operations

(In thousands, except per share amounts)

(Unaudited)

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Consolidated Balance Sheets

(In thousands, except per share amounts)

(Unaudited)

 EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

EXAMWORKS GROUP, INC. AND SUBSIDIARIES

Reconciliation to Adjusted EBITDA

(In thousands)

(Unaudited)